Clinical Indication

Type 2 diabetes


Conditional on prescriber being competent to select appropriate patients.

Local guidance

Use in line with NICE TA 315 only where dapagliflozin not suitable.

National guidance

NICE TA 315 

Date of classification

December 2014


Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.